Status:
COMPLETED
Quality of Life Validation in Laryngitis
Lead Sponsor:
AstraZeneca
Conditions:
Laryngopharyngeal Reflux (LPR)
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The primary purpose of this study was to establish the psychometric properties of a new disease specific Quality of Life questionnaire, the LPR-HRQL. The specific properties of the questionnaire that ...
Eligibility Criteria
Inclusion
- New Laryngopharyngeal reflux diagnosis less than 1 month or relapsed patients not under current treatment
Exclusion
- Unable to comply with study requirements.
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2003
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00641264
Start Date
May 1 2001
End Date
June 1 2003
Last Update
June 11 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.